Axial Therapeutics Announces $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis June 24, 2019
Calithera Achieves Positive Topline Results in Randomized Phase 2 Study in Renal Cell Carcinoma June 18, 2019
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age June 7, 2019
Axial Therapeutics Announces Publication of Preclinical Data Highlighting the Link Between Human Gut Microbiota and Behavioral Symptoms of Autism Spectrum Disorder in Mouse Models May 31, 2019
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study May 31, 2019
